In this article published in Medical Device News, Chris Dawson, Head of TTP's Biosensing team explores how CGM manufacturers can adapt to this growing market by:
- Designing flexible, user-friendly devices tailored to diverse needs
- Addressing adherence challenges with comfort, simplicity, and on-demand monitoring
- Supporting preventative health strategies with accessible, actionable insights
Read the article in Medical Device News to learn how evolving CGM hardware can better support Type 2 patients and set the standard for proactive diabetes management. Read the full article
About TTP’s Biosensing Consulting Team
Specialising in the development of wearable and implantable biosensors, TTP’s Biosensor product design and development consultants deploy multidisciplinary teams, combining expert capabilities to deliver tailored solutions that meet the most demanding project requirements.
Whether navigating uncharted territories, supporting your next innovation or accelerating time to market, we solve complex challenges with engineering and scientific rigour, finding and retiring risks early to deliver high-impact, human-centred results. When your internal bandwidth is constrained, TTP is ready to deliver.
Read more about how we are accelerating continuous glucose monitoring design and development.
TTP's Biosensing team is part of our broader Medical Device Consulting business unit, consisting of 300+ engineers, scientists, and human factors specialists. For nearly four decades we've partnered with clients to develop impactful solutions, helping them achieve commercial success. See our approach to medical device design and development.
